The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 337:1168-1170 October 16, 1997 Number 16
NextNext

Primary Coronary Angioplasty versus Thrombolysis

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators
-PubMed Citation
To the Editor: In the Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) substudy (June 5 issue),1 although the outcomes at 30 days with primary percutaneous transluminal coronary angioplasty (PTCA) were better than those with accelerated recombinant tissue plasminogen activator (t-PA), the relative reductions in death and reinfarction with PTCA were smaller than in the Primary Angioplasty in Myocardial Infarction (PAMI) trial, the trial in Zwolle, the Netherlands, and the Mayo Clinic trial.2,3,4 The base-line characteristics of the patients enrolled in these trials were similar to those of the patients enrolled in GUSTO . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.